期刊文献+

慢性阻塞性肺疾病急性加重期患者病原菌分布及耐药性分析 被引量:10

Investigation of etiology and drug resistance in lower respiratory tract infection patients with chronic obstructive pulmonary disease during acute exacerbation
原文传递
导出
摘要 目的了解某院慢性阻塞性肺疾病急性加重期(acute exacerbation of chronic obstructivepulmonary disease, AECOPD)患者下呼吸道病原菌分布及药敏情况,指导临床合理应用抗菌药物。方法对该院2007年4月至2011年12月住院的718例AECOPD患者痰培养及药敏结果进行回顾性分析。结果共分离出病原菌479株,其中革兰阴性杆菌266株(55.5%),主要为克雷伯菌属、铜绿假单胞菌、大肠埃希菌及不动杆菌属;革兰阳性球菌144株(30.1%),以葡萄球菌属和肺炎链球菌为主;真菌69株(14.4%),以白色假丝酵母菌为主。极重度COPD患者革兰阴性杆菌(64.7%vs59.8%vs49.1%)和真菌的检出率(20.6%vs18.5%vs9.0%)均高于重度和中度患者(革兰阴性杆菌χ2=7.42,P〈0.05;真菌χ2=9.95,P〈0.05)。革兰阴性杆菌耐药率较低的为亚胺培南、头孢哌酮/舒巴坦、多黏菌素、莫西沙星和阿米卡星;革兰阳性球菌耐药率较低的为万古霉素、替考拉宁、利奈唑胺、喹奴普汀/达福普汀和夫西地酸。结论AECOPD患者下呼吸道感染病原菌以革兰阴性杆菌为主,是肺功能差、病情严重的患者的优势致病菌。 Objective To investigate the characteristics of the distribution and drug resistance of bacteria in lower respiratory tract isolated from patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD) and guide clinical rational application of antimicrobial agents. Methods Sputum culture and antimicrobial susceptibility results of 718 patients with AECOPD who were hospitalized in a hospital between April 2007 and December 2011 were retrospectively analysed. Results A total of 479 strains were isolated from all sputum samples,55.5% of them were Gram-negative bacillus including Klebsiella,Pseudomonas aeruginosa,Escherichia colt and Acinetobacter as the main pathogens. 30.1% were Gram-positive cocci mainly including Staphylococcus and streptococcus pneumoniae. 14.4% were fungus athogens and Candida albicans was the most commom pathogens. The relevance ratio of Gram-negative bacillus (64.7% vs 59.8% vs 49.1%) and fungus (20.6% vs 18.5% vs 9.0%) in very severe patients was higher than in severe or moderate ones (gram negative bacillus: χ2= 7.42, P 〈0.05. fungal : χ2 = 9.95, P d0, 05). The results of drug sensitivity test were : most of the Gram-negative bacillis were more sensitive to imipenem, cefoperazone/sulbactam, polymyxin, moxifloxacin and amikacin and most of the Gram-positive bacilli were more sensitive to vaneomycin, teicoplanin, linezolid, quinupristin/ dalfopristirl and f usidic acid. Conclusions The main pathogenics in lower respiratory tract of patients with AECOPD were Gram-negative bacillus,which were the advantage ones of the more severe eases with poor lung function.
出处 《国际呼吸杂志》 2014年第15期1155-1159,共5页 International Journal of Respiration
关键词 慢性阻塞性肺疾病 细菌 病原学 耐药性 Chronic obstructive pulmonary disease Bacteria Etiology Drug resistance
  • 相关文献

参考文献17

  • 1Halpern MT,Stanford RH, Borker R. The burden of COPD in the U. S. A. : results from the Confronting COPD survey [J]. Respir Med, 2003,97 Suppl C, S81-S89.
  • 2Anzueto A. Impact of exacerbations on COPD[J]. Eur Respir Rev, 2010,19 : 113-118.
  • 3Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000:a state-of-the-art review[J]. Clin Microbiol Rev, 2001,14:336-363.
  • 4Iyer Parameswaran G, Murphy TF. Chronic obstructive pulmonary disease: role of bacteria and updated guide to antibacterial selection in the older patient[J]. Drugs Aging, 2009,26 : 985-995.
  • 5慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1790
  • 6Butorac-Petanjek B,Parnham MJ, Popovic-Grle S. Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD) [J]. J Chemother, 2010,22 291-297.
  • 7Montero M,Domlnguez M,Orozco-Levi M,et al. Mortality of COPD patients infected with. multi-resistant Pseudomonas aeruginosa:a case and control study[J]. Infection, 2009,37: 16-19.
  • 8Erkan L, Uzun O, Findik S, et al. Role of bacteria in acute exacerbations of chronic obstructive pulmonary disease[J]. Int J Chron Ohstruct Pulmon Dis, 2008,3 463-467.
  • 9Evensen AE. Management of COPD exacerbations[J]. Am Faro Physician,2010,81:607-613.
  • 10徐平,宋卫东,刘媛媛,皮佳俐,李延红,杨虹.慢性阻塞性肺疾病急性细菌性加重患者病原菌分析[J].中国感染与化疗杂志,2010,10(2):108-111. 被引量:21

二级参考文献31

共引文献1886

同被引文献90

  • 1刘雁冰,王燕,崔立波.慢性阻塞性肺疾病稳定期下呼吸道细菌定植状况[J].国际呼吸杂志,2007,27(14):1085-1089. 被引量:12
  • 2陈固萍,胡又专.慢性阻塞性肺疾病急性发作期患者病原菌分布与耐药分析[J].中国感染控制杂志,2007,6(5):338-341. 被引量:7
  • 3黄隽敏,徐爱晖,李永怀,郑凌.COPD急性加重期病原菌感染及耐药性分析[J].山东医药,2007,47(31):43-44. 被引量:9
  • 4Nseir S, Di Pompeo C, Cavestri B, et al. Multiple-durg-resist-ant bacteria in patients with severe acute exacerbation of chronic ob- structive pulmonary disease : Prevalence, risk factors, and outcome [Jl. Crit Care Med,2006,34(12) :2959 -2966.
  • 5Wilson R. Bacteria, antibiotics and C OPD [ J ]. Eur Respir J,2001, 17(5) :995 - 1007.
  • 6Kelly E,Owen CA,Pinto-Plata V,et al.The role of systemic inflammatory biomarkers to predict mortality in chronic obstructive pulmonary disease[J].Expert Rev Respir Med,2013,7(1):57-64.
  • 7Faurholt-Jepsen D.The double burden[J].Dan Med J,2013,60(7):B4673.
  • 8MacNee W.Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease[J].Ann Med,2013,45(3):291-300.
  • 9Pinto-Plata V,Casanova C,Müllerova H,et al.Inflammatory and repair serum biomarker pattern:association to clinical outcomes in COPD[J].Respir Res,2012,13:71.
  • 10Choroszy-Król I,Frej-Madrzak M,Hober M,et al.Infections caused by chlamydophila pneumoniae[J].Adv Clin Exp Med,2014,23(1):123-126.

引证文献10

二级引证文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部